Prevalence of Anxiety and Depression in Patients of End-Stage Renal Disease (ESRD) On Hemodialysis: A Single Centre Study

Rajeev Kumar Pandey; Sangeeta Kumari; Vidya Nand

doi:10.55489/njmr.150220251024

Authors

Rajeev Kumar Pandey Department of General Medicine, SRMS Institute of Medical Sciences, Bareilly, India
Sangeeta Kumari Department of Radiodiagnosis, SRMS Institute of Medical Sciences, Bareilly, India
Vidya Nand Department of General Medicine, SRMS Institute of Medical Sciences, Bareilly, India

DOI:

https://doi.org/10.55489/njmr.150220251024

Keywords:

End-stage renal disease, Hemodialysis, Anxiety, Depression, Prevalence, Hospital Anxiety and Depression Scale

Abstract

Background: End-stage renal disease (ESRD) necessitates hemodialysis (HD), a treatment associated with substantial physical and psychological burdens. Anxiety and depression are common in ESRD patients and can adversely impact their quality of life and treatment adherence. This study aimed to evaluate the prevalence of anxiety and depression among patients undergoing chronic HD.

Methods: A cross-sectional observational study was conducted at SRMS IMS Bareilly involving 100 ESRD patients on chronic HD. Patients completed the Hospital Anxiety and Depression Scale (HADS) to evaluate symptoms of anxiety and depression.

Results: Among the 100 patients, 68% exhibited depressive disorders, and 56% had anxiety disorders, with 24% showing both conditions. Depression was more prevalent among males (62.86%) compared to females (44.7%)-ODDs ratio-1.29. In contrast, anxiety was significantly higher in females (44.3%) compared to males (31.8%)-ODDs ratio-0.69. The prevalence of depression and anxiety varied across age Depression increases with age, being highest in individuals aged ≥60 years and lowest in those aged 18–39 years. Patients undergoing HD three times a week reported more depressive symptoms. Additionally, the use of central venous catheters correlated with increased psychological symptoms.

Conclusions: Depression and anxiety are prevalent among ESRD patients on HD, with significant gender disparities and an association with HD frequency. Addressing these psychological aspects through comprehensive care strategies is essential for improving patient outcomes.

References

Abbasi MA, Chertow GM, Hall YN. End-stage renal disease. BMJ Clin Evid. 2010;2010:1-16.

Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016;11:e0158765. DOI: https://doi.org/10.1371/journal.pone.0158765 PMid:27383068 PMCid:PMC4934905 DOI: https://doi.org/10.1371/journal.pone.0158765

Lopes AA, Bragg J, Young E, Goodkin D, Mapes D, Combe C, et al. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int. 2002;62:199-207. DOI: https://doi.org/10.1046/j.1523-1755.2002.00411.x PMid:12081579

Boulware LE, Liu Y, Fink NE, Coresh J, Ford DE, Klag MJ, et al. Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. Clin J Am Soc Nephrol.

Osthus TB, Dammen T, Sandvik L, Bruun CM, Nordhus IH, Os I. Health-related quality of life and depression in dialysis patients: associations with current smoking. Scand J Urol Nephrol. 2010;44:46-55. DOI: https://doi.org/10.3109/00365590903449324 PMid:20030569 DOI: https://doi.org/10.3109/00365590903449324

Cukor D, Coplan J, Brown C, Friedman S, Newville H, Safier M, et al. Anxiety disorders in adults treated by hemodialysis: a single-center study. Am J Kidney Dis. 2008;52:128-36. DOI: https://doi.org/10.1053/j.ajkd.2008.02.300 PMid:18440682 DOI: https://doi.org/10.1053/j.ajkd.2008.02.300

Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int. 2009;75:1223-9. DOI: https://doi.org/10.1038/ki.2009.51 PMid:19242502 DOI: https://doi.org/10.1038/ki.2009.51

Levy NB. What is psychonephrology? J Nephrol. 2008;21(Suppl 13):S51-3.

Kimmel PL.Psychosocial factors in dialysis patients.Kidney Int. 2001;59:1599-613. DOI: https://doi.org/10.1046/j.1523-1755.2001.0590041599.x PMid:11260433 DOI: https://doi.org/10.1046/j.1523-1755.2001.0590041599.x

Kimmel PL, Weihs K, Peterson RA. Survival in hemodialysis patients: the role of depression. J Am Soc Nephrol. 1993;4:12-27. DOI: https://doi.org/10.1681/ASN.V4112 PMid:8400064 DOI: https://doi.org/10.1681/ASN.V4112

Hedayati SS, Bosworth HB, Briley LP, et al. Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney Int. 2008;74:930-6. DOI: https://doi.org/10.1038/ki.2008.311 PMid:18580856 DOI: https://doi.org/10.1038/ki.2008.311

Lopes AA, Bragg J, Young E, et al. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int. 2002;62:199-207. DOI: https://doi.org/10.1046/j.1523-1755.2002.00411.x PMid:12081579 DOI: https://doi.org/10.1046/j.1523-1755.2002.00411.x

Fischer MJ, Xie D, Jordan N, Kop WJ, Krousel-Wood M, Tamura MK, et al. Factors associated with depressive symptoms and use of antidepressant medications among participants in the Chronic Renal Insufficiency Cohort (CRIC).

Kop WJ, Seliger SL, Fink JC, Katz R, Odden MC, Fried LF, et al. Longitudinal association of depressive symptoms with rapid kidney function decline and adverse clinical renal disease outcomes. Clin J Am Soc Nephrol. 2011;6(4):834-44. DOI: https://doi.org/10.2215/CJN.03840510 PMid:21393483 PMCid:PMC3069377 DOI: https://doi.org/10.2215/CJN.03840510

Murtagh FE, Addington Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14:82-99. DOI: https://doi.org/10.1053/j.ackd.2006.10.001 PMid:17200048 DOI: https://doi.org/10.1053/j.ackd.2006.10.001

Kumar V, Khandelia V, Garg A. Depression and anxiety in patients with chronic kidney disease undergoing hemodialysis. Ann Indian Psychiatry. 2018;2:115-9. DOI: https://doi.org/10.4103/aip.aip_12_18 DOI: https://doi.org/10.4103/aip.aip_12_18

Loosman WL, Siegert CE, Korzec A, Honig A. Validity of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory for use in end-stage renal disease patients. Br J Clin Psychol. 2010;49:507-16. DOI: https://doi.org/10.1348/014466509X477827 PMid:20021730 DOI: https://doi.org/10.1348/014466509X477827

Brennan C, Worrall Davies A, McMillan D, Gilbody S, House A. The Hospital Anxiety and Depression Scale: a diagnostic meta-analysis of case-finding ability.

Assari S. Chronic kidney disease, anxiety and depression among American blacks; does ethnicity matter? Int J Travel Med Glob Health. 2014;2:133-9.

Kimmel PL, Thamer M, Richard CM, Ray NF. Psychiatric illness in patients with end-stage renal disease. Am J Med. 1998;105:214-21. DOI: https://doi.org/10.1016/S0002-9343(98)00245-9 PMid:9753024 DOI: https://doi.org/10.1016/S0002-9343(98)00245-9

Hou Y, Li X, Yang L, Liu C, Wu H, Xu Y, et al. Factors associated with depression and anxiety in patients with end-stage renal disease receiving maintenance hemodialysis.

Gadia N, Depression and anxiety in patients of chronic kidney disease undergoing hemodialysis: A study from western Rajasthan.

Alanazi O, Al Mansour M, Sami W. Depression and quality of life in patients with chronic kidney disease on hemodialysis in Central Province in Saudi Arabia. Hamdan Med J. 2015;8:223. DOI: https://doi.org/10.7707/hmj.597 DOI: https://doi.org/10.7707/hmj.597

Camacho Á. Is anxious-depression an inflammatory state? Med Hypotheses. 2013;81:577-81. DOI: https://doi.org/10.1016/j.mehy.2013.07.006 PMid:23891039 PMCid:PMC3782383 DOI: https://doi.org/10.1016/j.mehy.2013.07.006

SqalliHoussaini T, Ramouz I, Fahi Z, Tahiri A, Sekkat FZ, Balafrej L. Effects of anxiety and depression on hemodialysis adequacy. Nephrol Ther. 2005;1:31-7. DOI: https://doi.org/10.1016/j.nephro.2005.01.007 PMid:16895665 DOI: https://doi.org/10.1016/j.nephro.2005.01.007

Mosleh H, Alenezi M, Al Johani S, Alsani A, Fairag G, Bedaiwi R. Prevalence and factors of anxiety and depression in chronic kidney disease patients undergoing hemodialysis: A cross-sectional single-center study in Saudi Arabia. Cureus. 2020;12:e6668. DOI: https://doi.org/10.7759/cureus.6668 PMid:31976185 PMCid:PMC6968827 DOI: https://doi.org/10.7759/cureus.6668

Sheayria F, Karkar AM, Almenawi LA, Alreemawi R, Awn N, Alzenim MM, et al. Stroke-free status and depression scores among Saudi dialysis patients. Ren Fail. 2015;37:392-7. DOI: https://doi.org/10.3109/0886022X.2014.996088 PMid:25578814 DOI: https://doi.org/10.3109/0886022X.2014.996088

Alshogran OY, Khalil AA, Oweis AO, et al. Association of brain-derived neurotrophic factor and interleukin-6 serum levels with depressive and anxiety symptoms in hemodialysis patients. Gen Hosp Psychiatry. 2018;53:25-31. DOI: https://doi.org/10.1016/j.genhosppsych.2018.04.003 PMid:29727764 DOI: https://doi.org/10.1016/j.genhosppsych.2018.04.003